subscribe
 

Virus-like particle vaccine protects monkeys

An experimental vaccine developed using non-infectious virus-like particles has protected macaques and mice against chikungunya virus, a...

Key to early stages of viral infection

Scientists have identified a molecule that defines which cells are destined to become memory T cells just a few days after a viral infection begins.

Advance in imaging of cell death

A new paper describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.

HIV researchers solve key puzzle

Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a recent study.

Hormone key to alcohol dependence

A team of scientists has found that a specific stress hormone, the corticotropin-releasing factor, is key to the development and maintenance of alcohol dependence in animal models.

Science in the media

A major new report into science and the media has drawn on research by Cardiff University which found that that in some respects specialist science news reporting in the UK is in relatively good health.

Potential way to reverse cancer cell metabolism

A team of scientists has discovered molecular factors in cancer cells that boost the production of an enzyme that helps alter the cells' glucose metabolism.

Ebola's deadly secret

Research at Iowa State University has led scientists to uncover how the deadly Zaire Ebola virus decoys cells and eventually kills them.

Compounds that help protect nerve cells

Scientists have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases.

How brain tumours outsmart drugs

Researchers have shown one way in which gliomas, a deadly type of brain tumour, can evade drugs aimed at blocking a key cell signaling protein, epidermal growth factor receptor (EGFR),that is crucial for tumour growth.

Bacterial membrane-coat proteins

A group of related bacteria in the superphylum Planctomycetes-Verrucomicrobia-Chlamydiae have remained in relative obscurity ever since they were first described about a decade ago.

Ending sleeping sickness

After many years of study, a team of researchers is releasing data today that it hopes will lead to new drug therapies that will kill the family of parasites that causes a deadly trio diseases.

Key EBV mechanism discovered

A team of researchers identified the function of a protein which plays a critical role in the proliferation of the Epstein-Barr virus which can induce cancer.

New function for Syndecan-4

Researchers have discovered a new function of a protein that could ultimately unlock the mystery of how these workhorses of the body play a central role in the mechanics of biological processes in people.

Synthesising Palau'amine

In 1993 researchers discovered a chemical compound in a sponge off Palau, an island nation in the Pacific Ocean, that has shown anticancer, antibacterial, and antifungal pharmaceutical promise.

Scientists create super-strong collagen

A team of researchers has created the strongest form of collagen known to science, a stable alternative to human collagen that could one day be used to treat arthritis and other conditions that result from collagen defects.

Key protein in ALS and frontotemporal dementia

Scientists at the Gladstone Institute of Neurological Disease have identified the reason a key protein plays a major role in two neurodegenerative diseases.

Discrimination among microbes

Scientists have learned Myxococcus xanthus cells are able to recognise genetic differences in one another that are so subtle, even the...

What came first in the origin of life?

Recent research rejects the theory that the origin of life stems from a system of self-catalytic molecules capable of experiencing Darwinian evolution without the need of RNA or DNA and their replication.

Discovery of enzyme activation process

Researchers have determined how a 'chemical chaperone' does its job in the body, which could lead to a new class of drugs to help reduce the muscle damage caused by heart attacks.

Pages

Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe